SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.12.09 | Novartis akkumulieren | Independent Research GmbH | |
| 09.12.09 | Novartis buy | Helvea | |
| 11.12.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 08.12.09 | Novartis buy | Citigroup Corp. | |
| 03.12.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 03.12.09 | Novartis buy | UBS AG | |
| 30.11.09 | Novartis buy | Helvea | |
| 26.11.09 | Novartis underperform | Cheuvreux SA | |
| 25.11.09 | Novartis outperform | Exane-BNP Paribas SA | |
| 24.11.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 24.11.09 | BB Biotech | Wirtschaftswoche | |
| 24.11.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 17.11.09 | Novartis akkumulieren | Independent Research GmbH | |
| 17.11.09 | Novartis | Wirtschaftswoche | |
| 16.11.09 | Novartis equal-weight | Morgan Stanley | |
| 13.11.09 | Novartis underweight | Barclays Capital | |
| 13.11.09 | Novartis | Focus Money | |
| 10.11.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 09.11.09 | Lonza kaufen | Die Actien-Börse | |
| 06.11.09 | Novartis | Der Aktionärsbrief | |
| 09.11.09 | Novartis buy | UBS AG | |
| 12.11.09 | Novartis kaufen | Raiffeisen Centrobank AG | |
| 22.10.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 22.10.09 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 22.10.09 | Novartis akkumulieren | Independent Research GmbH | |
| 22.10.09 | Novartis outperform | Cazenove Group Limited | |
| 21.10.09 | Novartis equal-weight | Morgan Stanley | |
| 14.10.09 | Novartis buy | Helvea | |
| 12.10.09 | Novartis outperform | Cowen and Company, LLC | |
| 12.10.09 | Novartis outperform | Cowen and Company, LLC | |
| 09.10.09 | Novartis buy | Citigroup Corp. | |
| 07.10.09 | Novartis kaufen | SEB AG | |
| 30.09.09 | Novartis buy | Citigroup Corp. | |
| 30.09.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 24.09.09 | Novartis | Focus Money | |
| 15.09.09 | Novartis buy | Jefferies & Company Inc. | |
| 10.09.09 | Novartis outperform | Exane-BNP Paribas SA | |
| 09.09.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 08.09.09 | Novartis buy | Goldman Sachs Group Inc. | |
| 08.09.09 | Novartis buy | Nomura |